Slideshow: 5 Must-Reads from 2014

Before we say goodbye to 2014, we’d like to ring in the new year with 5 important stories in case you missed them. These articles go to the heart of our mission to change the conversation about side effects.

[metaslider id=5816]

In the past year, we looked at long- and short-term side effects of many kinds of prescription drugs, and at ways to lessen those side effects, from finding alternative medications to making lifestyle changes. We published First Person accounts about finding the right pharmaceuticals for bipolar disorder and learning how important it is to get all the information you need from your doctor.

MedShadow Blog continues to be the voice of the website. Written by MedShadow Foundation creator Su Robotti, the blog challenges the FDA, the pharmaceutical industry and sometime conventional wisdom.

We also introduced a new blog, FDA Watch by Sarah Smedley, and keep posting in-the-news items we think you should know about.

And we’ll be doing all of the above — and more — in 2015.

Wishing you and your family a joyous and healthy New Year.


Did you find this article helpful?


Latest News

Breaking News – EpiPen Malfunction

Breaking News – EpiPen Malfunction

Just released from the FDA – Pfizer has informed the FDA that they are aware of several continuing problems that people are having using the EpiPen (epinephrine) and EpiPen Jr (epinephrine) auto-injectors and generic versions. Some of the problems are from user error and some from EpiPen malfunction. Here are…

ACE Inhibitors in the Time of Coronavirus

ACE Inhibitors in the Time of Coronavirus

Are you worried about ACE inhibitors and coronavirus? You may be hearing that one of the entry methods for the coronavirus in humans is by attaching to the ACE-2 enzyme. This has raised alarms among those with heart disease who use ACE inhibitors (with names ending in -pril, such as…

  • Advertisement